KIF22 Polyclonal Antibody

KIF22 Polyclonal Antibody

The KIF22 Polyclonal Antibody is a highly specific and sensitive antibody that has been designed to detect and quantify the expression of KIF22 protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human KIF22 protein. The resulting polyclonal antibody has been purified using a combination of protein A and protein G affinity chromatography to ensure high purity and specificity.

KIF22 is a member of the kinesin superfamily of microtubule-based motor proteins that play a critical role in various cellular processes, including mitosis, cytokinesis, and intracellular transport. The expression of KIF22 is upregulated in various types of cancer, making it an attractive target for cancer therapy. The KIF22 Polyclonal Antibody can be used to study the expression and localization of KIF22 in cancer cells and tissues, as well as in normal cells and tissues.

The KIF22 Polyclonal Antibody has been validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been shown to specifically detect KIF22 protein in various human cell lines and tissues, including breast cancer cell lines and breast cancer tissues. The antibody has also been shown to be highly sensitive, with a detection limit of 0.1 ng/mL.

In summary, the KIF22 Polyclonal Antibody is a highly specific and sensitive antibody that can be used to study the expression and localization of KIF22 protein in various biological samples. Its high purity and specificity make it an ideal tool for cancer research and drug development.